Viewing Study NCT01476332


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2026-03-06 @ 10:47 AM
Study NCT ID: NCT01476332
Status: COMPLETED
Last Update Posted: 2012-05-17
First Post: 2011-11-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)
Sponsor: Laurantis Pharma, Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dry Eye View
Keywords:

Keywords

Keyword Brief Keyword Text View
None eyes View
None cis-urocanic acid View
None safety View
None tolerability View
None pharmacokinetics View